Clinical Trials Logo

Placental Abruption clinical trials

View clinical trials related to Placental Abruption.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04168606 Completed - Placenta Diseases Clinical Trials

Study on Retroplacental Hematomas in Finistère

HEMOPLACENTA
Start date: September 23, 2019
Phase:
Study type: Observational

Cases with placental abruption will be identified by interrogation of two databases of Brest University Hospital between January 2013 and December 2018. First trimester PAPPA and bhCG levels will be recorded. PlGF levels will be measured in women with an available first trimester serum sample. Histological findings in placentas, course of pregnancies, maternal and fetal characteristics will described and compared between cases with and without placental chronic inflammation.

NCT ID: NCT03455387 Completed - Pre-Eclampsia Clinical Trials

Evaluation of the Serum Markers sFLt1 and PlGF for the Prediction of the Complications of the Placental Vascular Pathologies in the 3rd Quarter of the Pregnancy.

PRECOPE
Start date: January 10, 2017
Phase:
Study type: Observational

The pre-eclampsia is a frequent pathology, concerning approximately 5 % of the pregnancies.The pre-eclampsia can evolve into severe maternal and\or foetal complications and is a major cause of mortality. The purpose of the study will to estimate the relevance of the serum markers sFlt1 and PlGF to predict the arisen of severe complications at these patients, what would allow to decrease the materno-fœtale morbi-mortality due to the pathology.